Aflibercept 8 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aflibercept 8 mg, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Retrospective Multicenter Real-world Observational Study of Switching to Aflibercept 8 mg in Patients With Refractory or Dependent Exudative Age-related Macular Degeneration